Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVRx, Inc.CVRX · Entity 6920 | CHIEF HUMAN RESOURCES OFFICER | March 02, 2026 | March 04, 2026 |
| Wright Medical Group N.V.WMGI · Entity 145358 | SVP, Human Resources | November 10, 2017 | November 14, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVRx, Inc.
Report date March 02, 2026 · Filed March 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,000 |
Reported balance
After 2026-03-02 transaction · row 1
1 source rowRow 1 · 2026-03-02 · Grant · Acquired 34,000 · Balance 34,000 F1: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.22 · Expires 2036-03-01 | Direct | 154,500 |
Reported balance
After 2026-03-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-03-02 · Grant · Acquired 154,500 · Balance 154,500 F2: Vests as to 25% of the shares on March 2, 2027 and as to 1/48th of the shares each month thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.
F2: Vests as to 25% of the shares on March 2, 2027 and as to 1/48th of the shares each month thereafter.
Wright Medical Group N.V.
Report date November 10, 2017 · Filed November 14, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value EUR 0.03 per shareSEC Table I · non-derivative | Direct | 35,488 |
Last balance in matching sequence
After 2017-11-13 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rowsRow 1 · 2017-11-10 · Exercise / conversion · Acquired 10,899 · Balance 88,387 F1: Includes 22,680 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,989 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Row 2 · 2017-11-10 · Exercise / conversion · Acquired 39,241 · Balance 127,628 F1: Includes 22,680 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,989 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Row 3 · 2017-11-10 · Sale · Disposed 50,140 · Balance 77,488 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.62 to $24.02, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F1: Includes 22,680 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,989 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Row 4 · 2017-11-13 · Sale · Disposed 42,000 · Balance 35,488 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.51 to $23.82, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. F1: Includes 22,680 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,989 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.24 · Expires 2026-07-19 | Direct | 23,991 |
Reported balance
After 2017-11-10 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-11-10 · Exercise / conversion · Disposed 10,899 · Balance 23,991 F4: This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.62 · Expires 2025-10-13 | Direct | 39,307 |
Reported balance
After 2017-11-10 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-11-10 · Exercise / conversion · Disposed 39,241 · Balance 39,307 F5: This option vested with respect to 25% of the shares on October 13, 2016 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 22,680 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,989 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.62 to $24.02, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.51 to $23.82, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
F4: This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
F5: This option vested with respect to 25% of the shares on October 13, 2016 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2026 Filed Mar 4, 2026 21:34 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 154,500 | $0.00 Strike: $8.22 | $0.00 |
DisclosureSEC source: 0001329922-26-000006 · form4-03042026_090343.xml · derivative · entry 2 Morrison Gregory · CIK 0001329922 · CHIEF HUMAN RESOURCES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,500 Underlying: Common Stock · 154,500 shares Expires 2036-03-01 F2 · derivative.exercise_date: Vests as to 25% of the shares on March 2, 2027 and as to 1/48th of the shares each month thereafter. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:34 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantCommon Stock | 34,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001329922-26-000006 · form4-03042026_090343.xml · nonDerivative · entry 1 Morrison Gregory · CIK 0001329922 · CHIEF HUMAN RESOURCES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,000 F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 16:34 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 42,000 | $23.65 | $993,102.60 |
DisclosureSEC source: 0001235802-17-000168 · primary_doc.xml · nonDerivative · entry 4 Morrison Gregory · CIK 0001329922 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,488 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.51 to $23.82, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. F1 · balance_after: Includes 22,680 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,989 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 16:34 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Exercise / conversionStock Option (right to buy) · Derivative | 39,241 | $20.62 Strike: $20.62 | $809,149.42 |
DisclosureSEC source: 0001235802-17-000168 · primary_doc.xml · derivative · entry 6 Morrison Gregory · CIK 0001329922 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,307 Underlying: Ordinary Shares · 39,241 shares Expires 2025-10-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option vested with respect to 25% of the shares on October 13, 2016 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 16:34 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Exercise / conversionStock Option (right to buy) · Derivative | 10,899 | $21.24 Strike: $21.24 | $231,494.76 |
DisclosureSEC source: 0001235802-17-000168 · primary_doc.xml · derivative · entry 5 Morrison Gregory · CIK 0001329922 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,991 Underlying: Ordinary Shares · 10,899 shares Expires 2026-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 16:34 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 50,140 | $23.74 | $1,190,418.87 |
DisclosureSEC source: 0001235802-17-000168 · primary_doc.xml · nonDerivative · entry 3 Morrison Gregory · CIK 0001329922 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,488 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.62 to $24.02, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F1 · balance_after: Includes 22,680 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,989 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 16:34 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Exercise / conversionOrdinary Shares, par value EUR 0.03 per share | 39,241 | $20.62 | $809,149.42 |
DisclosureSEC source: 0001235802-17-000168 · primary_doc.xml · nonDerivative · entry 2 Morrison Gregory · CIK 0001329922 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,628 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 22,680 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,989 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 16:34 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Exercise / conversionOrdinary Shares, par value EUR 0.03 per share | 10,899 | $21.24 | $231,494.76 |
DisclosureSEC source: 0001235802-17-000168 · primary_doc.xml · nonDerivative · entry 1 Morrison Gregory · CIK 0001329922 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 22,680 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,989 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document |
| July 25, 2017 Filed Jul 26, 2017 18:49 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GrantStock Option (right to buy) · Derivative | 17,681 | $0.00 Strike: $27.86 | $0.00 |
DisclosureSEC source: 0001235802-17-000133 · primary_doc.xml · derivative · entry 2 Morrison Gregory · CIK 0001329922 · Sr VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,681 Underlying: Ordinary Shares · 17,681 shares Expires 2027-07-25 F3 · derivative.exercise_date: This option vests with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. Read SEC document |
| July 25, 2017 Filed Jul 26, 2017 18:49 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GrantOrdinary Shares, par value EUR 0.03 per share | 5,989 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-17-000133 · primary_doc.xml · nonDerivative · entry 1 Morrison Gregory · CIK 0001329922 · Sr VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,488 F1 · shares: These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. F2 · balance_after: Includes 22,680 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,989 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 16:58 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 2,773 | $27.09 | $75,120.57 |
DisclosureSEC source: 0001235802-17-000068 · primary_doc.xml · nonDerivative · entry 1 Morrison Gregory · CIK 0001329922 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,499 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.99 to $27.24, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Includes 22,680 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.